PCN19 The Cost-Effectiveness of Bendamustine-Rituximab (Ben-R) Versus R-Chop for the First Line Treatment of Patients with Indolent Non-Hodgkin’s Lymphoma (Inhl) in Colombia

Details

Language :

English

ISSN :

10983015

Issue :

7

Database :

OpenAIRE

Journal :

Value in Health

Accession number :

edsair.core.ac.uk....70c151c641f85af1a3f10658e3460faa

Full Text :

https://doi.org/10.1016/j.jval.2015.09.247